首页 > 最新文献

Public Health Action最新文献

英文 中文
Association between low water intake and lung function impairment in elderly adults: a cross-sectional study. 老年人低饮水量与肺功能损害之间的关系:一项横断面研究。
IF 1.6 Q4 RESPIRATORY SYSTEM Pub Date : 2026-03-06 eCollection Date: 2026-03-01 DOI: 10.5588/pha.25.0038
P-C Wang, Y-F Wu, M-S Lin, Y-C Tu, S-Y Huang, J-H Lung, C-S Shi, M-Y Chen

Background: This study aimed to investigate the association between water intake and lung function impairment, focusing on the potential effect of dehydration on respiratory health in elderly adults.

Methods: A community-based, cross-sectional study was conducted in rural regions of Taiwan between March and December 2022. A total of 888 participants were enrolled. Data collection included lung function tests, physiological measurements, demographic characteristics, and medical histories. The effects of various variables on lung function were analysed across different age groups.

Results: Both restrictive and obstructive lung function impairment were significantly associated with older age, low water intake, and lower educational attainment. Restrictive lung function impairment was additionally correlated with the presence of cardiometabolic diseases, whereas obstructive lung function impairment was associated with male sex and smoking. Among participants aged over 65 years, low water consumption was associated with increased odds of restrictive and obstructive lung function impairment.

Conclusion: Low water intake is associated with an increased risk of both restrictive and obstructive lung function impairment, particularly in elderly adults. Public health interventions promoting adequate hydration may help preserve pulmonary function in elderly population.

背景:本研究旨在探讨饮水量与肺功能损害之间的关系,重点研究脱水对老年人呼吸系统健康的潜在影响。方法:于2022年3月至12月在台湾农村地区进行以社区为基础的横断面研究。共有888名参与者被纳入研究。数据收集包括肺功能测试、生理测量、人口统计学特征和病史。在不同年龄组中分析了各种变量对肺功能的影响。结果:限制性和阻塞性肺功能损害均与年龄较大、饮水量低、受教育程度低相关。限制性肺功能损害还与心脏代谢疾病的存在相关,而阻塞性肺功能损害与男性和吸烟有关。在65岁以上的参与者中,低饮水量与限制性和阻塞性肺功能损害的几率增加有关。结论:低水摄入量与限制性和阻塞性肺功能损害的风险增加有关,特别是在老年人中。促进适当水合作用的公共卫生干预可能有助于保护老年人的肺功能。
{"title":"Association between low water intake and lung function impairment in elderly adults: a cross-sectional study.","authors":"P-C Wang, Y-F Wu, M-S Lin, Y-C Tu, S-Y Huang, J-H Lung, C-S Shi, M-Y Chen","doi":"10.5588/pha.25.0038","DOIUrl":"https://doi.org/10.5588/pha.25.0038","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to investigate the association between water intake and lung function impairment, focusing on the potential effect of dehydration on respiratory health in elderly adults.</p><p><strong>Methods: </strong>A community-based, cross-sectional study was conducted in rural regions of Taiwan between March and December 2022. A total of 888 participants were enrolled. Data collection included lung function tests, physiological measurements, demographic characteristics, and medical histories. The effects of various variables on lung function were analysed across different age groups.</p><p><strong>Results: </strong>Both restrictive and obstructive lung function impairment were significantly associated with older age, low water intake, and lower educational attainment. Restrictive lung function impairment was additionally correlated with the presence of cardiometabolic diseases, whereas obstructive lung function impairment was associated with male sex and smoking. Among participants aged over 65 years, low water consumption was associated with increased odds of restrictive and obstructive lung function impairment.</p><p><strong>Conclusion: </strong>Low water intake is associated with an increased risk of both restrictive and obstructive lung function impairment, particularly in elderly adults. Public health interventions promoting adequate hydration may help preserve pulmonary function in elderly population.</p>","PeriodicalId":46239,"journal":{"name":"Public Health Action","volume":"16 1","pages":"41-46"},"PeriodicalIF":1.6,"publicationDate":"2026-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12991752/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147475828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diabetes mellitus, TB, and HIV multi-morbidities among adults in Uganda. 乌干达成年人中糖尿病、结核病和艾滋病毒的多重发病率。
IF 1.6 Q4 RESPIRATORY SYSTEM Pub Date : 2026-03-06 eCollection Date: 2026-03-01 DOI: 10.5588/pha.25.0032
J E Akumu, C Sekaggya-Wiltshire, S Babirye, J Musaazi, P E Kukundakwe, C Okiira, E Mutebi, S Nabadda, P Namuwenge, H Sendagire

Objective: Antiretroviral therapy has extended HIV patient survival, increasing non-communicable disease prevalence like diabetes mellitus. Strong links exist between HIV, TB, and diabetes. This study examined diabetes prevalence among adults with TB and HIV, or co-infection in Uganda.

Design: Cross-sectional study conducted between August 2021 and January 2022 at three urban hospitals in Kampala, Uganda. Participants aged ≥18 years receiving HIV and/or TB treatment for at least 6 months were enrolled. Diabetes screening was performed using random blood glucose and haemoglobin A1C measurements according to American Diabetes Association guidelines.

Results: Among 924 participants, 832 (90.0%) had HIV only, 50 (5.4%) had TB only, and 42 (4.6%) had both conditions. Overall diabetes prevalence was 4.1% in HIV patients, 7.6% in TB patients, and 14.3% in TB-HIV co-infected patients. Diabetes was significantly more prevalent among older patients (≥36 years) across all disease categories and among males with HIV infection compared to females (6.8% vs. 3.0%, P = 0.011). Among TB patients, central obesity was associated with higher diabetes prevalence (33.3% vs. 4.2%, P = 0.007).

Conclusion: The study reveals elevated diabetes prevalence among patients with TB-HIV co-infection, emphasising the need for integrated screening and management strategies addressing these interconnected conditions in Uganda.

目的:抗逆转录病毒治疗延长了艾滋病毒患者的生存期,增加了糖尿病等非传染性疾病的患病率。艾滋病毒、结核病和糖尿病之间存在密切联系。这项研究调查了乌干达结核病和艾滋病毒合并感染的成年人中糖尿病的患病率。设计:横断面研究于2021年8月至2022年1月在乌干达坎帕拉的三家城市医院进行。受试者年龄≥18岁,接受HIV和/或TB治疗至少6个月。根据美国糖尿病协会指南,随机测量血糖和血红蛋白A1C进行糖尿病筛查。结果:在924名参与者中,832名(90.0%)仅患有艾滋病毒,50名(5.4%)仅患有结核病,42名(4.6%)同时患有两种疾病。总体糖尿病患病率在HIV患者中为4.1%,在TB患者中为7.6%,在TB-HIV合并感染患者中为14.3%。在所有疾病类别中,糖尿病在老年患者(≥36岁)和感染艾滋病毒的男性中比女性更普遍(6.8%比3.0%,P = 0.011)。在结核病患者中,中心性肥胖与较高的糖尿病患病率相关(33.3% vs. 4.2%, P = 0.007)。结论:该研究揭示了结核病-艾滋病毒合并感染患者中糖尿病患病率升高,强调了乌干达需要针对这些相互关联的疾病进行综合筛查和管理策略。
{"title":"Diabetes mellitus, TB, and HIV multi-morbidities among adults in Uganda.","authors":"J E Akumu, C Sekaggya-Wiltshire, S Babirye, J Musaazi, P E Kukundakwe, C Okiira, E Mutebi, S Nabadda, P Namuwenge, H Sendagire","doi":"10.5588/pha.25.0032","DOIUrl":"https://doi.org/10.5588/pha.25.0032","url":null,"abstract":"<p><strong>Objective: </strong>Antiretroviral therapy has extended HIV patient survival, increasing non-communicable disease prevalence like diabetes mellitus. Strong links exist between HIV, TB, and diabetes. This study examined diabetes prevalence among adults with TB and HIV, or co-infection in Uganda.</p><p><strong>Design: </strong>Cross-sectional study conducted between August 2021 and January 2022 at three urban hospitals in Kampala, Uganda. Participants aged ≥18 years receiving HIV and/or TB treatment for at least 6 months were enrolled. Diabetes screening was performed using random blood glucose and haemoglobin A1C measurements according to American Diabetes Association guidelines.</p><p><strong>Results: </strong>Among 924 participants, 832 (90.0%) had HIV only, 50 (5.4%) had TB only, and 42 (4.6%) had both conditions. Overall diabetes prevalence was 4.1% in HIV patients, 7.6% in TB patients, and 14.3% in TB-HIV co-infected patients. Diabetes was significantly more prevalent among older patients (≥36 years) across all disease categories and among males with HIV infection compared to females (6.8% vs. 3.0%, <i>P</i> = 0.011). Among TB patients, central obesity was associated with higher diabetes prevalence (33.3% vs. 4.2%, <i>P</i> = 0.007).</p><p><strong>Conclusion: </strong>The study reveals elevated diabetes prevalence among patients with TB-HIV co-infection, emphasising the need for integrated screening and management strategies addressing these interconnected conditions in Uganda.</p>","PeriodicalId":46239,"journal":{"name":"Public Health Action","volume":"16 1","pages":"63-68"},"PeriodicalIF":1.6,"publicationDate":"2026-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12991685/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147474836","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Viral load testing coverage and suppression rate among children and adolescents on ART in Sierra Leone. 塞拉利昂儿童和青少年接受抗逆转录病毒治疗的病毒载量检测覆盖率和抑制率。
IF 1.6 Q4 RESPIRATORY SYSTEM Pub Date : 2026-03-06 eCollection Date: 2026-03-01 DOI: 10.5588/pha.25.0053
F Kanu, F Lansana, M Mustapha, E K Tabor, P Thekkur, I F Kamara, B D Fofanah, J S Kanu, N Sesay, I S Turay, J A Koroma, W K Lahai, A M Falama, M A Sesay, S Lakoh

Setting: Anti-retroviral treatment (ART) centres from eight districts of Sierra Leone.

Objectives: Among children and adolescents (0-19 years) registered for ART after January 2023 and currently on care, to assess i) viral load (VL) testing coverage and viral suppression, ii) turnaround time from sample collection to results, and iii) factors associated with not undergoing testing.

Design: A cohort study using programmatic data extracted from April to October 2025.

Results: Of 950 participants, 931 (98%) were eligible for VL testing (on ART for ≥6 months). Of the total participants, 286 (30%) underwent VL testing at least once (coverage), of which 247 (86%) had viral suppression. Median turnaround time was 36 days, ranging from 6 days in districts with centralised VL testing laboratory to 65 days in a district far from the central laboratory. Participants from ART centres situated in the Western Area Urban district (adjusted relative risk: 1.8, 95% confidence interval: 1.0-3.1) were at higher risk of not undergoing VL testing.

Conclusion: Although high viral suppression was appreciable, less than one third of children and adolescents underwent VL testing with a long turnaround time, delaying virological failure detection and appropriate care. The national AIDS control programme should decentralise VL testing and strengthen sample transportation to ensure equitable access.

环境:塞拉利昂八个区的抗逆转录病毒治疗中心。目的:在2023年1月之后注册接受抗逆转录病毒治疗且目前正在接受治疗的儿童和青少年(0-19岁)中,评估i)病毒载量(VL)检测覆盖率和病毒抑制,ii)从样本收集到结果的周转时间,以及iii)未接受检测的相关因素。设计:采用2025年4月至10月的程序化数据进行队列研究。结果:在950名参与者中,931名(98%)符合VL检测(ART治疗≥6个月)。在所有参与者中,286人(30%)接受了至少一次VL检测(覆盖率),其中247人(86%)有病毒抑制。中位周转时间为36天,有集中VL检测实验室的地区为6天,而远离中心实验室的地区为65天。来自西部城区ART中心的参与者(调整相对风险:1.8,95%置信区间:1.0-3.1)不接受VL检测的风险较高。结论:虽然有明显的高病毒抑制,但只有不到三分之一的儿童和青少年接受了VL检测,而且周转时间长,延误了病毒学失败的检测和适当的护理。国家艾滋病控制规划应分散VL检测并加强样本运输,以确保公平获取。
{"title":"Viral load testing coverage and suppression rate among children and adolescents on ART in Sierra Leone.","authors":"F Kanu, F Lansana, M Mustapha, E K Tabor, P Thekkur, I F Kamara, B D Fofanah, J S Kanu, N Sesay, I S Turay, J A Koroma, W K Lahai, A M Falama, M A Sesay, S Lakoh","doi":"10.5588/pha.25.0053","DOIUrl":"https://doi.org/10.5588/pha.25.0053","url":null,"abstract":"<p><strong>Setting: </strong>Anti-retroviral treatment (ART) centres from eight districts of Sierra Leone.</p><p><strong>Objectives: </strong>Among children and adolescents (0-19 years) registered for ART after January 2023 and currently on care, to assess i) viral load (VL) testing coverage and viral suppression, ii) turnaround time from sample collection to results, and iii) factors associated with not undergoing testing.</p><p><strong>Design: </strong>A cohort study using programmatic data extracted from April to October 2025.</p><p><strong>Results: </strong>Of 950 participants, 931 (98%) were eligible for VL testing (on ART for ≥6 months). Of the total participants, 286 (30%) underwent VL testing at least once (coverage), of which 247 (86%) had viral suppression. Median turnaround time was 36 days, ranging from 6 days in districts with centralised VL testing laboratory to 65 days in a district far from the central laboratory. Participants from ART centres situated in the Western Area Urban district (adjusted relative risk: 1.8, 95% confidence interval: 1.0-3.1) were at higher risk of not undergoing VL testing.</p><p><strong>Conclusion: </strong>Although high viral suppression was appreciable, less than one third of children and adolescents underwent VL testing with a long turnaround time, delaying virological failure detection and appropriate care. The national AIDS control programme should decentralise VL testing and strengthen sample transportation to ensure equitable access.</p>","PeriodicalId":46239,"journal":{"name":"Public Health Action","volume":"16 1","pages":"15-21"},"PeriodicalIF":1.6,"publicationDate":"2026-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12991605/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147475469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A qualitative study of home- versus facility-based TB treatment for adolescents in Lima, Peru. 秘鲁利马青少年家庭与机构结核病治疗的定性研究。
IF 1.6 Q4 RESPIRATORY SYSTEM Pub Date : 2025-12-03 eCollection Date: 2025-12-01 DOI: 10.5588/pha.25.0025
B Roman-Sinche, F M Doradea, K Tintaya, L Lecca, S S Chiang

Background: Prior to the COVID-19 pandemic, TB treatment in Peru was delivered almost exclusively through facility-based directly observed therapy (DOT). During the pandemic, selected adolescents were allowed home-based TB treatment under caregiver supervision, along with video-supported treatment (VST) for adolescents with access to a smartphone.

Methods: We conducted 16 focus groups, each with 4-10 participants of adolescents with rifampicin-susceptible TB, their caregivers, and health care workers (HCWs). We used semi-structured guides to gather perspectives on facility-based DOT versus home-based treatment. Two authors applied inductive thematic analysis and identified emerging themes.

Results: HCWs assigned facility-based DOT or home-based treatment based on subjective assessment of the adolescent's level of responsibility and support from caregivers. Almost all adolescents and caregivers preferred home-based treatment because it reduced disruptions to routine activities, TB-related stigma, and costs. A few disagreed, stating that facility-based DOT was better for guaranteeing adherence and support for adverse drug reactions. Most HCWs preferred facility-based DOT because they did not feel confident about adherence without direct visualisation by a provider, even with VST; moreover, they found VST to be time-consuming.

Conclusion: Home-based TB treatment benefits adolescents and caregivers but must be further modified to achieve feasibility and acceptability among HCWs.

背景:在2019冠状病毒病大流行之前,秘鲁的结核病治疗几乎完全通过基于设施的直接观察治疗(DOT)提供。在大流行期间,允许选定的青少年在护理人员监督下进行家庭结核病治疗,并允许青少年使用智能手机进行视频支持治疗。方法:我们进行了16个焦点小组,每个小组有4-10名患有利福平敏感结核病的青少年、他们的照顾者和卫生保健工作者(HCWs)。我们使用半结构化指南来收集基于设施的DOT与基于家庭的治疗的观点。两位作者运用归纳性主题分析,确定了新兴主题。结果:卫生保健工作者根据青少年的责任水平和照顾者的支持的主观评估,分配了以设施为基础的DOT或以家庭为基础的治疗。几乎所有青少年和照料者都倾向于家庭治疗,因为它减少了对日常活动的干扰,减少了与结核病有关的污名和费用。少数人不同意,指出以设施为基础的DOT更好地保证依从性和对药物不良反应的支持。大多数HCWs更喜欢基于设施的DOT,因为如果没有提供者的直接可视化,即使有VST,他们对依从性也没有信心;此外,他们发现VST很耗时。结论:以家庭为基础的结核病治疗使青少年和护理人员受益,但必须进一步改进以实现卫生保健工作者的可行性和可接受性。
{"title":"A qualitative study of home- versus facility-based TB treatment for adolescents in Lima, Peru.","authors":"B Roman-Sinche, F M Doradea, K Tintaya, L Lecca, S S Chiang","doi":"10.5588/pha.25.0025","DOIUrl":"10.5588/pha.25.0025","url":null,"abstract":"<p><strong>Background: </strong>Prior to the COVID-19 pandemic, TB treatment in Peru was delivered almost exclusively through facility-based directly observed therapy (DOT). During the pandemic, selected adolescents were allowed home-based TB treatment under caregiver supervision, along with video-supported treatment (VST) for adolescents with access to a smartphone.</p><p><strong>Methods: </strong>We conducted 16 focus groups, each with 4-10 participants of adolescents with rifampicin-susceptible TB, their caregivers, and health care workers (HCWs). We used semi-structured guides to gather perspectives on facility-based DOT versus home-based treatment. Two authors applied inductive thematic analysis and identified emerging themes.</p><p><strong>Results: </strong>HCWs assigned facility-based DOT or home-based treatment based on subjective assessment of the adolescent's level of responsibility and support from caregivers. Almost all adolescents and caregivers preferred home-based treatment because it reduced disruptions to routine activities, TB-related stigma, and costs. A few disagreed, stating that facility-based DOT was better for guaranteeing adherence and support for adverse drug reactions. Most HCWs preferred facility-based DOT because they did not feel confident about adherence without direct visualisation by a provider, even with VST; moreover, they found VST to be time-consuming.</p><p><strong>Conclusion: </strong>Home-based TB treatment benefits adolescents and caregivers but must be further modified to achieve feasibility and acceptability among HCWs.</p>","PeriodicalId":46239,"journal":{"name":"Public Health Action","volume":"15 4","pages":"149-154"},"PeriodicalIF":1.6,"publicationDate":"2025-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12687127/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145726854","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patients with infectious TB who resist and refuse isolation in wards in Japan, 2022-2024. 2022-2024年,日本病房中抵抗和拒绝隔离的传染性结核病患者。
IF 1.6 Q4 RESPIRATORY SYSTEM Pub Date : 2025-12-03 eCollection Date: 2025-12-01 DOI: 10.5588/pha.25.0022
Y Nagata, M Ota, T Zama, S Hirao

Background: In Japan, a low-TB-burden country, approximately 4000 cases of sputum smear-positive TB are reported annually and the patients are typically isolated in a TB ward until they become smear-negative. However, there are some patients who resist or refuse isolation. This study aims to characterize these patients.

Methods: A descriptive study. A self-administered questionnaire was sent to local health offices about patients registered from April 2022 to March 2024 who resisted or refused isolation.

Results: A total of 71 patients (0.99%) who resisted or refused isolation were identified among 7,186 with smear-positive TB in the study period. In 2022, 22 (31.0%) such cases were reported, whereas there were 49 (69.0%) in 2023. Fifty-seven of these patients (80.3%) were male, with age that peaked in their 70s, 61 (85.9%) were born in Japan, and 28 (39.4%) were unemployed. Tokyo, the capital, reported 13 (18.3%) such cases, followed by Osaka (12, 16.9%) and Saitama (8, 11.3%) prefectures, whereas 24 (51.1%) of 47 prefectures reported none.

Conclusion: Although the number of patients with TB who resisted or refused isolation was small, there should be one or two TB facilities with law enforcement officials readily available to enforce isolation.

背景:在结核病低负担国家日本,每年报告的痰涂片阳性结核病病例约有4000例,患者通常在结核病病房隔离,直到痰涂片阴性。然而,也有一些患者抵制或拒绝隔离。本研究旨在对这些患者进行特征分析。方法:描述性研究。对2022年4月至2024年3月登记的抗拒或拒绝隔离的患者,向当地卫生办公室发送了一份自我填写的问卷。结果:研究期间,7186例涂阳结核患者中有71例(0.99%)抵抗或拒绝分离。2022年报告22例(31.0%),2023年报告49例(69.0%)。其中男性57人(80.3%),年龄以70多岁为高峰,在日本出生的61人(85.9%),无业28人(39.4%)。首都东京报告了13例(18.3%),其次是大阪(12.16.9%)和埼玉县(8.11.3%),而47个县中有24个县(51.1%)没有报告。结论:虽然抵制或拒绝隔离的结核病患者人数很少,但应该有一两个结核病设施,执法人员随时可以执行隔离。
{"title":"Patients with infectious TB who resist and refuse isolation in wards in Japan, 2022-2024.","authors":"Y Nagata, M Ota, T Zama, S Hirao","doi":"10.5588/pha.25.0022","DOIUrl":"10.5588/pha.25.0022","url":null,"abstract":"<p><strong>Background: </strong>In Japan, a low-TB-burden country, approximately 4000 cases of sputum smear-positive TB are reported annually and the patients are typically isolated in a TB ward until they become smear-negative. However, there are some patients who resist or refuse isolation. This study aims to characterize these patients.</p><p><strong>Methods: </strong>A descriptive study. A self-administered questionnaire was sent to local health offices about patients registered from April 2022 to March 2024 who resisted or refused isolation.</p><p><strong>Results: </strong>A total of 71 patients (0.99%) who resisted or refused isolation were identified among 7,186 with smear-positive TB in the study period. In 2022, 22 (31.0%) such cases were reported, whereas there were 49 (69.0%) in 2023. Fifty-seven of these patients (80.3%) were male, with age that peaked in their 70s, 61 (85.9%) were born in Japan, and 28 (39.4%) were unemployed. Tokyo, the capital, reported 13 (18.3%) such cases, followed by Osaka (12, 16.9%) and Saitama (8, 11.3%) prefectures, whereas 24 (51.1%) of 47 prefectures reported none.</p><p><strong>Conclusion: </strong>Although the number of patients with TB who resisted or refused isolation was small, there should be one or two TB facilities with law enforcement officials readily available to enforce isolation.</p>","PeriodicalId":46239,"journal":{"name":"Public Health Action","volume":"15 4","pages":"169-172"},"PeriodicalIF":1.6,"publicationDate":"2025-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12687123/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145726837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Financing the future of TB control: from dependence to resilience. 为结核病控制的未来提供资金:从依赖到复原力。
IF 1.6 Q4 RESPIRATORY SYSTEM Pub Date : 2025-12-03 eCollection Date: 2025-12-01 DOI: 10.5588/pha.25.0037
G N Kazi

Recent cuts in international donor funding threaten global progress in TB control, particularly in countries that are heavily reliant on external support. With TB still the deadliest infectious disease, reduced funding could lead to millions of preventable cases and deaths. However, this crisis also presents an opportunity: governments must increase domestic investment, integrate TB care into broader health systems, and build resilient, patient-centered services. Doing so strengthens pandemic preparedness and addresses climate-related health risks. Ultimately, sustained progress against TB requires strong national leadership to move from donor dependency to self-reliant, equitable and sustainable health systems.

最近国际捐助资金的减少威胁到结核病控制方面的全球进展,特别是在严重依赖外部支持的国家。由于结核病仍然是最致命的传染病,减少资金可能导致数百万可预防的病例和死亡。然而,这场危机也提供了一个机会:各国政府必须增加国内投资,将结核病治疗纳入更广泛的卫生系统,并建立有弹性的、以患者为中心的服务。这样做可加强大流行防范并应对与气候有关的健康风险。最终,要在防治结核病方面取得持续进展,就需要强有力的国家领导,从依赖捐助者转向自力更生、公平和可持续的卫生系统。
{"title":"Financing the future of TB control: from dependence to resilience.","authors":"G N Kazi","doi":"10.5588/pha.25.0037","DOIUrl":"10.5588/pha.25.0037","url":null,"abstract":"<p><p>Recent cuts in international donor funding threaten global progress in TB control, particularly in countries that are heavily reliant on external support. With TB still the deadliest infectious disease, reduced funding could lead to millions of preventable cases and deaths. However, this crisis also presents an opportunity: governments must increase domestic investment, integrate TB care into broader health systems, and build resilient, patient-centered services. Doing so strengthens pandemic preparedness and addresses climate-related health risks. Ultimately, sustained progress against TB requires strong national leadership to move from donor dependency to self-reliant, equitable and sustainable health systems.</p>","PeriodicalId":46239,"journal":{"name":"Public Health Action","volume":"15 4","pages":"143-144"},"PeriodicalIF":1.6,"publicationDate":"2025-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12687125/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145726820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Can high private cough syrup sales act as a proxy for missed TB notifications in TB surveillance? 私人止咳糖浆的高销量是否可以作为结核病监测中遗漏结核病报告的代表?
IF 1.6 Q4 RESPIRATORY SYSTEM Pub Date : 2025-12-03 eCollection Date: 2025-12-01 DOI: 10.5588/pha.25.0033
K Gupta, H D Shewade, P Manickam, P Soni, V N Baig, R Dagar, M Parmar, Y Saxena, S Charan, H Abdullah, A K Bhardwaj

Background: Rajasthan in India, is a high TB burden state with a high prevalence to notification ratio. This gap calls for alternative strategies to find the non-notified people with TB. Because cough is the most prominent symptom of TB and cough syrups are one of the highest over the counter drugs in India, its sale might be used as a proxy for missed TB cases.

Methods: This was an ecological study to assess the correlation between cough syrup sales and missed TB notifications in the private sector. We calculated the missed TB notification rate as the difference between the estimated people on TB treatment and TB notification in the private sector from January 2021 to March 2023, across all districts of Rajasthan (n = 33). We analysed district level mean quarterly cough syrup sales and TB notification rates/100,000 population.

Results: We found positive correlation between cough syrup sales and TB notification [overall (r = 0.43), private (r = 0.63) and missed private TB notification (r = 0.39)]. Based on this analysis, missed TB notification rates were 7x more than the reported notifications in the private sector.

Conclusion: We recommend a private sector-based TB surveillance system with TB screening for people who approach pharmacies for cough syrup.

背景:印度拉贾斯坦邦是结核病高负担州,发病率与通报率高。这一差距要求采取替代战略来发现未通报的结核病患者。由于咳嗽是结核病最突出的症状,而咳嗽糖浆是印度非处方药中使用率最高的药物之一,因此其销量可能被用作漏诊结核病病例的代表。方法:这是一项生态学研究,旨在评估私营部门止咳糖浆销售与漏报结核病之间的相关性。我们计算了拉贾斯坦邦所有地区2021年1月至2023年3月期间接受结核病治疗的估计人数与私营部门结核病通报人数之间的差异,即遗漏结核病通报率(n = 33)。我们分析了区级平均季度止咳糖浆销售和结核病通报率/10万人。结果:我们发现止咳糖浆销售与结核病通报呈正相关[总体(r = 0.43),私人(r = 0.63)和遗漏的私人结核病通报(r = 0.39)]。根据这一分析,结核病漏报率比私营部门报告的通报率高出7倍。结论:我们建议建立以私营部门为基础的结核病监测系统,对到药店购买止咳糖浆的人进行结核病筛查。
{"title":"Can high private cough syrup sales act as a proxy for missed TB notifications in TB surveillance?","authors":"K Gupta, H D Shewade, P Manickam, P Soni, V N Baig, R Dagar, M Parmar, Y Saxena, S Charan, H Abdullah, A K Bhardwaj","doi":"10.5588/pha.25.0033","DOIUrl":"10.5588/pha.25.0033","url":null,"abstract":"<p><strong>Background: </strong>Rajasthan in India, is a high TB burden state with a high prevalence to notification ratio. This gap calls for alternative strategies to find the non-notified people with TB. Because cough is the most prominent symptom of TB and cough syrups are one of the highest over the counter drugs in India, its sale might be used as a proxy for missed TB cases.</p><p><strong>Methods: </strong>This was an ecological study to assess the correlation between cough syrup sales and missed TB notifications in the private sector. We calculated the missed TB notification rate as the difference between the estimated people on TB treatment and TB notification in the private sector from January 2021 to March 2023, across all districts of Rajasthan (n = 33). We analysed district level mean quarterly cough syrup sales and TB notification rates/100,000 population.</p><p><strong>Results: </strong>We found positive correlation between cough syrup sales and TB notification [overall (r = 0.43), private (r = 0.63) and missed private TB notification (r = 0.39)]. Based on this analysis, missed TB notification rates were 7x more than the reported notifications in the private sector.</p><p><strong>Conclusion: </strong>We recommend a private sector-based TB surveillance system with TB screening for people who approach pharmacies for cough syrup.</p>","PeriodicalId":46239,"journal":{"name":"Public Health Action","volume":"15 4","pages":"164-168"},"PeriodicalIF":1.6,"publicationDate":"2025-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12687120/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145726828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Laboratory strengthening strategies to advance drug susceptibility testing for BPaL regimens in TB treatment. 加强实验室战略,促进结核治疗中BPaL方案的药敏试验。
IF 1.6 Q4 RESPIRATORY SYSTEM Pub Date : 2025-12-03 eCollection Date: 2025-12-01 DOI: 10.5588/pha.25.0014
J-K Jung, J S Lee, A Slyzkyi, D F Wares, S N Cho

Background: To support BPaL (bedaquiline [Bdq], pretomanid [Pa] and linezolid [Lzd]) rollout, countries require ongoing technical and policy support for standardized drug susceptibility testing (DST).

Methods: The Leveraging Innovation for the Faster Treatment of Tuberculosis (LIFT-TB) operational research project aimed to strengthen laboratory capacity for DST in 7 countries (the Philippines, Myanmar, Indonesia, Vietnam, Uzbekistan, Kyrgyzstan and Ukraine) through needs assessments, reagent and equipment support, quality control and training.

Results: During the project, we trained 157 professionals in phenotypic and molecular DST, enhancing quality assurance and implementation. We found there was variable DST capacity and resistance patterns.

Conclusion: Our study highlights the need for continued investment in training and infrastructure to integrate DST into routine diagnostics and to support scale-up of BPaL regimens in high TB-burden settings.

背景:为了支持BPaL(贝达喹啉[Bdq]、普雷托马尼[Pa]和利奈唑胺[Lzd])的推广,各国需要对标准化药敏试验(DST)提供持续的技术和政策支持。方法:利用创新促进结核病快速治疗(LIFT-TB)业务研究项目旨在通过需求评估、试剂和设备支持、质量控制和培训,加强7个国家(菲律宾、缅甸、印度尼西亚、越南、乌兹别克斯坦、吉尔吉斯斯坦和乌克兰)的实验室DST能力。结果:在项目期间,我们培训了157名表型和分子DST专业人员,加强了质量保证和实施。我们发现存在可变的DST容量和电阻模式。结论:我们的研究强调需要继续投资培训和基础设施,将DST纳入常规诊断,并支持在结核病高负担地区扩大BPaL方案。
{"title":"Laboratory strengthening strategies to advance drug susceptibility testing for BPaL regimens in TB treatment.","authors":"J-K Jung, J S Lee, A Slyzkyi, D F Wares, S N Cho","doi":"10.5588/pha.25.0014","DOIUrl":"10.5588/pha.25.0014","url":null,"abstract":"<p><strong>Background: </strong>To support BPaL (bedaquiline [Bdq], pretomanid [Pa] and linezolid [Lzd]) rollout, countries require ongoing technical and policy support for standardized drug susceptibility testing (DST).</p><p><strong>Methods: </strong>The Leveraging Innovation for the Faster Treatment of Tuberculosis (LIFT-TB) operational research project aimed to strengthen laboratory capacity for DST in 7 countries (the Philippines, Myanmar, Indonesia, Vietnam, Uzbekistan, Kyrgyzstan and Ukraine) through needs assessments, reagent and equipment support, quality control and training.</p><p><strong>Results: </strong>During the project, we trained 157 professionals in phenotypic and molecular DST, enhancing quality assurance and implementation. We found there was variable DST capacity and resistance patterns.</p><p><strong>Conclusion: </strong>Our study highlights the need for continued investment in training and infrastructure to integrate DST into routine diagnostics and to support scale-up of BPaL regimens in high TB-burden settings.</p>","PeriodicalId":46239,"journal":{"name":"Public Health Action","volume":"15 4","pages":"145-148"},"PeriodicalIF":1.6,"publicationDate":"2025-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12687124/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145726816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Building peer information exchange networks to improve child and adolescent TB care in Sub-Saharan Africa. 建立同行信息交流网络,以改善撒哈拉以南非洲的儿童和青少年结核病护理。
IF 1.6 Q4 RESPIRATORY SYSTEM Pub Date : 2025-12-03 eCollection Date: 2025-12-01 DOI: 10.5588/pha.25.0036
R Mande, S D Berger, B Moore, P Thekkur, J P Dongo, J Doyle, J Harris, S M Graham, R A Dlodlo

The Sub-Saharan Africa Regional Child and Adolescent TB Centre of Excellence (COE) was established in 2019 to address gaps in child and adolescent TB care in the region. The COE promotes the south-to-south exchange of best practices and innovation through virtual and in-person engagements, including webinars, workshops, and annual meetings. The COE's training efforts, including an interactive curriculum, have strengthened capacity that has increased TB detection and enhanced knowledge among health professionals.

撒哈拉以南非洲地区儿童和青少年结核病卓越中心于2019年成立,旨在解决该地区儿童和青少年结核病护理方面的差距。COE通过虚拟和面对面的接触,包括网络研讨会、讲习班和年会,促进最佳实践和创新的南对南交流。COE的培训工作,包括互动式课程,加强了能力,提高了结核病检测和卫生专业人员的知识。
{"title":"Building peer information exchange networks to improve child and adolescent TB care in Sub-Saharan Africa.","authors":"R Mande, S D Berger, B Moore, P Thekkur, J P Dongo, J Doyle, J Harris, S M Graham, R A Dlodlo","doi":"10.5588/pha.25.0036","DOIUrl":"10.5588/pha.25.0036","url":null,"abstract":"<p><p>The Sub-Saharan Africa Regional Child and Adolescent TB Centre of Excellence (COE) was established in 2019 to address gaps in child and adolescent TB care in the region. The COE promotes the south-to-south exchange of best practices and innovation through virtual and in-person engagements, including webinars, workshops, and annual meetings. The COE's training efforts, including an interactive curriculum, have strengthened capacity that has increased TB detection and enhanced knowledge among health professionals.</p>","PeriodicalId":46239,"journal":{"name":"Public Health Action","volume":"15 4","pages":"179-182"},"PeriodicalIF":1.6,"publicationDate":"2025-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12687126/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145726885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Active TB case finding in returnee coalminers and their home district communities in Pakistan. 在巴基斯坦归国矿工及其家乡社区发现活动性结核病例。
IF 1.6 Q4 RESPIRATORY SYSTEM Pub Date : 2025-12-03 eCollection Date: 2025-12-01 DOI: 10.5588/pha.25.0031
K U Eman, G N Kazi, U R Lodhi, B Kirubi, M Ali, M Shahzad, F Siraj, S A Raisani, S Ashraf, S John, S Tahseen, J Creswell

Setting: Five districts with large coalmining workforces in Pakistan.

Objective: To assess the burden of TB among returnee coalminers (RCMs) and associated community members (ACMs) in their home districts through active case finding (ACF).

Design: This cross-sectional study (October 2020-September 2021) used portable chest X-ray (CXR) with artificial intelligence (AI) in camps and verbal screening in camps and communities. Individuals screening positive were tested with GeneXpert, and those diagnosed were initiated on TB treatment.

Results: A total of 150,242 individuals were screened, including 44% RCMs. Of these, 8.3% underwent CXR, 10% verbal screening in camps, and 81% verbal screening in communities. Symptoms were reported by 45% of RCMs and 15% of ACMs, while CXR abnormalities were comparable. TB was diagnosed in 226 RCMs and 204 ACMs, with overall prevalence per 100,000 of 341 (95% confidence interval [CI]: 296-385) and 243 (95% CI: 209-276), respectively. TB prevalence varied by screening strategy and was significantly higher among those screened with CXR: 1,156 in RCMs and 497 in ACMs.

Conclusion: AI-assisted CXR was substantially more effective than verbal screening, detecting significantly higher numbers of TB cases among RCMs and ACMs, supporting its use for targeted ACF in high-risk populations.

背景:巴基斯坦有五个地区有大量的煤矿工人。目的:通过主动病例发现法(ACF)评估回国矿工及其相关社区成员(acm)在家乡地区的结核病负担。设计:本横断面研究(2020年10月至2021年9月)在营地使用便携式胸部x射线(CXR)和人工智能(AI),并在营地和社区进行口头筛查。筛查呈阳性的个体用GeneXpert进行了检测,确诊者开始接受结核病治疗。结果:共筛查150,242例,其中rcm占44%。其中8.3%接受了CXR, 10%在营地接受了口头筛查,81%在社区接受了口头筛查。45%的rcm和15%的ACMs报告了症状,而CXR异常相似。在226个rcm和204个acm中诊断出结核病,其中每10万人中有341人(95%可信区间[CI]: 296-385)和243人(95%可信区间:209-276)的总患病率分别为每10万人中有341人和243人(95%可信区间:209-276)。结核病患病率因筛查策略而异,在接受CXR筛查的人群中显著较高:rcm为1156人,ACMs为497人。结论:人工智能辅助CXR比口头筛查更有效,在rcm和acm中发现的结核病病例数量明显更高,支持其用于高危人群的靶向ACF。
{"title":"Active TB case finding in returnee coalminers and their home district communities in Pakistan.","authors":"K U Eman, G N Kazi, U R Lodhi, B Kirubi, M Ali, M Shahzad, F Siraj, S A Raisani, S Ashraf, S John, S Tahseen, J Creswell","doi":"10.5588/pha.25.0031","DOIUrl":"10.5588/pha.25.0031","url":null,"abstract":"<p><strong>Setting: </strong>Five districts with large coalmining workforces in Pakistan.</p><p><strong>Objective: </strong>To assess the burden of TB among returnee coalminers (RCMs) and associated community members (ACMs) in their home districts through active case finding (ACF).</p><p><strong>Design: </strong>This cross-sectional study (October 2020-September 2021) used portable chest X-ray (CXR) with artificial intelligence (AI) in camps and verbal screening in camps and communities. Individuals screening positive were tested with GeneXpert, and those diagnosed were initiated on TB treatment.</p><p><strong>Results: </strong>A total of 150,242 individuals were screened, including 44% RCMs. Of these, 8.3% underwent CXR, 10% verbal screening in camps, and 81% verbal screening in communities. Symptoms were reported by 45% of RCMs and 15% of ACMs, while CXR abnormalities were comparable. TB was diagnosed in 226 RCMs and 204 ACMs, with overall prevalence per 100,000 of 341 (95% confidence interval [CI]: 296-385) and 243 (95% CI: 209-276), respectively. TB prevalence varied by screening strategy and was significantly higher among those screened with CXR: 1,156 in RCMs and 497 in ACMs.</p><p><strong>Conclusion: </strong>AI-assisted CXR was substantially more effective than verbal screening, detecting significantly higher numbers of TB cases among RCMs and ACMs, supporting its use for targeted ACF in high-risk populations.</p>","PeriodicalId":46239,"journal":{"name":"Public Health Action","volume":"15 4","pages":"173-178"},"PeriodicalIF":1.6,"publicationDate":"2025-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12687118/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145726801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Public Health Action
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1